top of page



Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: An updated systematic review and meta-analysis including the 2-year STEP 5 trial. Diabetes Obes Metab. 2023 Nov 28. doi: 10.1111/dom.15386. Epub ahead of print. PMID: 38016699.


Diabetes Obes Metab

介入試験, メタ解析

セマグルチド2.4mg vs プラセボで
体重 -11.8%[-12.93、-10. 68] -12.2g[-13.3、-11.1]
消化器系副作用リスク比:1.49 [1.38, 1.60]

bottom of page